What Is the Treatment of Opisthorchiasis?
Opisthorchiasis is a parasitic liver fluke infection that requires targeted antiparasitic therapy. A well-established treatment framework exists, with a primary oral agent of choice and a recognised oral alternative for cases where the first option is not suitable.
Clinical Scenario
This protocol addresses the pharmacological management of Opisthorchiasis (ICD-11 1F84 / ICD-10 B66.0) as a first-line intervention. The regimen applies to both adult and pediatric patients, with the same class of drug used across age groups.
Treatment Approach — Partial Summary
Praziquantel is the treatment of choice for Opisthorchis infections; albendazole is available as an oral alternative. The complete regimen — including the dosing schedule, treatment duration, administration timing, and specific guidance on bioavailability — is contained in the full structured protocol.
References
- Praziquantel is the treatment of choice for Opisthorchis infections.
- Albendazole is an alternative drug option.
- Both oral praziquantel and oral albendazole are available for human use in the United States.